<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-Q26FGEKL</identifier><date>2013</date><creator>Ivanuš, Urška</creator><creator>Primic-Žakelj, Maja</creator><relation>documents/doc/Q/URN_NBN_SI_doc-Q26FGEKL_001.pdf</relation><relation>documents/doc/Q/URN_NBN_SI_doc-Q26FGEKL_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 27-34</format><identifier identifier_type="COBISSID_HOST">1514107</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-Q26FGEKL</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>Zbornik - Izobraževalni dan programa ZORA 4</source><rights>InC</rights><subject language_type_id="slv">citopatologija</subject><subject language_type_id="slv">maternični vrat</subject><subject language_type_id="slv">presejalni programi</subject><subject language_type_id="slv">presejanje za raka materničnega vratu</subject><subject language_type_id="slv">triažni testi</subject><title>Uporaba triažnega testa HPV v programu ZORA v letu 2012</title></Record>